Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Tenofovir generic patent?When does guselkumab patent expire?Can grapefruit consumption affect lipitor's efficacy?Patent term adjustment semaglutida?Does lipitor's use influence blood pressure medication type?
See the DrugPatentWatch profile for vascepa
Who Should Be Careful with Vascepa Dose? Vascepa (icosapent ethyl) is a prescription medication used to lower triglyceride levels in individuals with high triglycerides, often seen in people with diabetes or heart disease. The recommended dose of Vascepa is one 1,000 mg or two 500 mg capsules taken orally once a day with a meal [1]. Medication Interactions and Dose Alteration According to the medication guide provided by Vascepa's manufacturer, medications with specific characteristics that affect bile acid sequestrants, HMG-CoA reductase inhibitors, and fibrates are of concern [2]. Some interactions include: - Gemfibrozil: Vascepa's dosage should be reduced to 250 mg daily in patients taking gemfibrozil, an antilipemic agent, as the combination may raise the risk of gastrointestinal side effects [3]. - Fibrate drugs: Co-administration with gemfibrozil, fenofibrate, and other fibrates can increase the risk of gastrointestinal side effects and necessitate a reduced dose of Vascepa. - Warfarin and other anticoagulants: Monitor the international normalized ratio (INR) in patients taking warfarin, as changes in INR levels may occur when Vascepa is co-administered. - Anti-hyperlipidemic statins: Concomitant administration with statins doesn't necessitate dose alteration, but the effect on triglyceride levels may be reduced. Prescription Considerations Healthcare professionals should consult the full prescribing information to determine the best course of action when prescribing Vascepa, particularly when interacting with other medications. They must make informed decisions about potential dose alterations based on patient factors and ongoing medication usage [4]. References: [1] Vascepa, Icosapent Ethyl Capsules, prescribing information. https://www.vascepa.com/pi/PI_Vascepa.pdf [2] Vascepa, Icosapent Ethyl Capsules, medication guides. https://www.vascepa.com/medguide [3] DrugPatentWatch.com. 2022 https://drugpatentwatch.com/drug/vascepa [4] Vascepa, Icosapent Ethyl Capsules, product labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210774s000lbl.pdf
Other Questions About Vascepa :